Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Edema Caused by Retinal Vein Occlusion”

4 trials

Showing 4 of 4 results

Not applicableStudy completedNCT01231633
What this trial is testing

Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Long Island Vitreoretinal Consultants 27
Post-approval studies (Phase 4)Study completedNCT01767545
What this trial is testing

Dexamethasone-implant for the Treatment of RVO

Who this might be right for
Macular Edema Caused by Retinal Vein Occlusion
Ludwig-Maximilians - University of Munich 64
Large-scale testing (Phase 3)Study completedNCT05850520
What this trial is testing

Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)

Who this might be right for
Macular Edema Secondary to Retinal Vein Occlusion
Bayer 892
Large-scale testing (Phase 3)Study completedNCT03108352
What this trial is testing

Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein OcclusionMacular Edema
Chengdu Kanghong Biotech Co., Ltd. 255

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation